New study aims to improve cervical cancer screening for women in botswana

NCT ID NCT04242823

Ongoing Diagnosis Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study evaluates different cervical cancer screening methods using HPV testing in Botswana, involving 3000 women aged 25 and older. Researchers compare HPV genotype restriction with visual inspection to find the most accurate way to detect high-grade cervical dysplasia. The goal is to improve screening, especially for women living with HIV, and make it more feasible in low-resource settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to more effective and affordable cervical cancer screening programs in low- and middle-income countries, especially for women living with HIV.
What could go wrong: This is an observational study, not a treatment trial. Results may not apply to other regions or populations, and the screening methods may not be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER PREVENTION

Contacts and locations

Locations

Bamalete Lutheran Hospital

Ramotswa, Botswana

More trials for these conditions

Other studies related to the condition(s) this trial covers.